2 terminated, 1 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Deepa Jagadeesh: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ME-401 and R-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma ME-401, Rituximab, Cyclophosphamide - Diffuse Large B-Cell Lymphoma | Phase 1 / Phase 2 | Terminated | Deepa Jagadeesh | 13 | 2021-04-28 | 2025-02-07 |
| Rituximab and Acalabrutinib in Newly Diagnosed B Cell Post Transplant Lymphoproliferative Disorder Rituximab, Acalabrutinib, CT scans - Post-transplant Lymphoproliferative Disorder | Phase 2 | Terminated | Deepa Jagadeesh | 6 | 2020-09-02 | 2024-04-10 |
| A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL) Brentuximab vedotin - T-cell Lymphoma, Angioimmunoblastic T-cell Lymphoma | Phase 2 | Completed | Deepa Jagadeesh | 23 | 2016-06-17 | 2025-11-21 |
Enteropathy-Associated T-Cell Lymphoma (1) · Immunoblastic Lymphadenopathy (1) · Leukemia (1) · Lymphoma (1) · Lymphoma, Extranodal NK-T-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, T-Cell (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
Rituximab (2) · Brentuximab Vedotin (1) · Cyclophosphamide (1) · Doxorubicin (1) · ME-401 (1) · Prednisone (1) · Tomography, X-Ray Computed (1) · Vincristine (1) · acalabrutinib (1)
United States (3)
Paolo Caimi, MD (1)